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ABSTRACT 
In this study, the effects of an aqueous extract of the leaves of Tridax procumbens on the 
haematology, plasma biochemistry and ocular indices of oxidative stress was investigated in 
alloxan induced diabetic rats. Diabetes mellitus was induced by injection of alloxan 
(80 mg/kg body weight), via the tail vein. The extract was administered orally at 100, 200 and 
300 mg/kg (both to normal and diabetic rats), and metformin at 50 mg/kg. On gas chromato-
graphic analysis of the alkaloid fraction of the aqueous extract, thirty nine known alkaloids 
were detected, consisting mainly of 73.91 % akuamidine, 22.33 % voacangine, 1.27 % echi-
tamine, 0.55 % echitamidine, 0.36 % lupanine, 0.27 % crinamidine, 0.23 % augustamine and 
0.10 % 6-hydroxypowelline. Tannic acid and β-sitosterol were detected in high quantities. 
Compared to Test control, the treatment dose-dependently, significantly lowered (P<0.05) 
plasma glucose, triglyceride, very low density lipoprotein cholesterol, total bilirubin, urea, 
blood urea nitrogen; plasma alkaline phosphatase, alanine and aspartate transaminases, and 
ocular superoxide dismutase activities, and lymphocyte count. It also significantly increased 
(P<0.05) plasma calcium and ocular ascorbic acid contents, haemoglobin concentration and 
neutrophil count. This study showed that the extract was hypoglycemic, positively affected 
the haemopoietic system and integrity and function (dose dependently) of the liver and kidney 
of the diabetic rats; improved the lipid profile and had no deleterious effect on red cell mor-
phology and protected against oxidative stress in ocular tissues. This study also revealed the 
presence of pharmacologically active compounds in the leaf extract. All of these, highlight the 
cardioprotective potential of the leaves of Tridax procumbens, and support its use in tradition-
al health care practices for the management of diabetes mellitus. 
Keywords: β-sitosterol, hypoglycemia, lipid profile, ocular oxidative stress, tannic acid, 
Tridax procumbens Linn 
 
 
 
INTRODUCTION 
Diabetes mellitus is a group of metabol-
ic diseases characterized by elevated glu-
cose in the plasma resulting from defects in 
insulin secretion, insulin action, or both 
(American Diabetes Association, 2004; 
Centers for Disease Control and Prevention, 
2008; Wardlaw, 1999). In Nigeria and other 
African populations, the past two decades 
has witnessed the emergence of type 2 dia-
betes mellitus as a major health problem, 
affecting about 2-7 % of these populations 
(Rolfe et al., 1992; Amos et al., 1997). The 
WHO 2004 report estimated that 1.7 mil-
lion people in Nigeria had diabetes, with 
the projection that the number will triple by 
2030 (World Health Organization, 2004). 
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Presently, there is renewed interest in 
the use of herbal products. This may be at-
tributable to the down turn in the economy, 
as herbal medicine is perceived to be a 
cheaper means of treatment (Kamboj, 2000; 
Acuff et al., 2007). Herbal products can im-
prove glucose metabolism and the overall 
condition of individuals with diabetes, not 
only by hypoglycemic effects but also by 
improving lipid metabolism, antioxidant 
status, and capillary function (Bailey and 
Day, 1989). Tridax procumbens is one of a 
number of medicinal herbs that is used in 
traditional health care practices for the 
management of diabetes mellitus. 
Tridax procumbens Linn (Family Aster-
aceae) is native to Central America and 
tropical South America, but has spread 
throughout the tropical and subtropical 
parts of the world. Its common names are 
coat buttons, tridax daisy, tridax (United 
States Department of Agriculture, Agricul-
tural Research Service, 2011). The Ibo peo-
ple of South Eastern Nigeria call it “mbuli”. 
It has daisy-like yellow centered white or 
yellow flowers with three toothed ray floret. 
The leaves are short, hairy and arrow 
shaped (Jahangir, 2001). It produces a hard 
achene fruit that is covered with stiff hairs 
(Fosberg and Sachet, 1980). It is used as an 
ornamental or fodder plant, and its leaves 
are cooked as vegetables (Acharya and Sri-
vastava, 2010; Prajapati et al., 2008). Tradi-
tionally, it is used for the treatment of bron-
chial catarrh, malaria, stomach ache, diar-
rhoea, epilepsy, diabetes, high blood pres-
sure, haemorrhage, liver problems, and as a 
hair tonic (Agrawal et al., 2010; Ahirwar et 
al., 2010; Hemalatha, 2008; Jahangir, 2001; 
Ravikumar et al., 2005). It possesses anti-
septic, insecticidal, parasiticidal properties 
and has marked depressant action on respi-
ration (Edeoga et al., 2005; Salahdeen et al., 
2004; Saxena and Albert, 2005).  
Ikewuchi et al. (2009) and Ikewuchi and 
Ikewuchi (2009a, b) reported the nutri-
ent/nutraceutical potential of the leaves. 
The protective effects of aqueous extract of 
the leaves against cholesterol and salt load-
ing in Wistar albino rats (Ikewuchi and 
Ikewuchi, 2009c: Ikewuchi et al., 2010), as 
well as its weight reducing (Ikewuchi et al., 
2011a) and hypotensive (Ikewuchi et al., 
2011b) activities have also been reported. 
Prabhu et al. (2011) reported the analgesic 
activity of the leaves. In this study, the ef-
fects of an aqueous extract of the leaves of 
Tridax procumbens Linn on haematology, 
plasma biochemistry and ocular indices of 
oxidative stress in normal and alloxan-
induced diabetic Wistar rats were investi-
gated. 
 
MATERIALS AND METHODS 
Preparation of plant extract  
Samples of the fresh Tridax procum-
bens plants (Figure 1) were collected from 
within the Choba and Abuja Campuses of 
University of Port Harcourt, Nigeria. After 
due identification at the University of Port 
Harcourt Herbarium, Port Harcourt, Nige-
ria, the identity was confirmed/authent-
icated by Dr. Michael C. Dike of the Tax-
onomy Unit, Department of Forestry and 
Environmental Management, Michael Ok-
para University of Agriculture, Umudike, 
Abia State, Nigeria; and Mr. John Ibe, the 
Herbarium Manager of the Forestry De-
partment, National Root Crops Research 
Institute (NRCRI), Umuahia, Nigeria. The 
samples were rid of dirt and the leaves re-
moved, oven dried at 55°C and ground into 
powder. The resultant powder was soaked 
in hot, boiled distilled water for 12 h, after 
which the resultant mixture was filtered and 
the filtrate, hereinafter referred to as the 
aqueous extract was stored in a refrigerator 
for subsequent use. A known volume of this 
extract was evaporated to dryness, and the 
weight of the residue used to determine the 
concentration of the filtrate, which was in 
turn used to determine the dose of admin-
istration of the extract. The resultant residue 
was used for the phytochemical study. 
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Determination of the phytochemical con-
tent of the crude aqueous leaf extract 
 
Calibration, identification and quantifica-
tion  
Standard solutions were prepared in 
methanol for alkaloids and tannins, and 
methylene chloride for phytosterols. The 
linearity of the dependence of response on 
concentration was verified by regression 
analysis. Identification was based on com-
parison of retention times and spectral data 
with standards. Quantification was per-
formed by establishing calibration curves 
for each compound determined, using the 
standards. 
 
Determination of alkaloid composition  
The extraction was carried out accord-
ing to the method of Tram et al. (2002). The 
alkaloid fraction of the crude aqueous ex-
tract was extracted with methanol and sub-
jected to gas chromatographic analysis. 
Chromatographic analyses were carried out 
on an HP 6890 (Hewlett Packard, Wilming-
ton, DE, USA), GC apparatus, fitted with a 
flame ionization detector (FID), and pow-
ered with HP Chemstation Rev. A 09.01 
(1206) software, to quantify and identify 
compounds. The column was a capillary 
DB-5MS (30 m × 0.25 mm × 0.25 μm film 
thickness). The inlet and detection tempera-
tures were 250 and 320 °C. Split injection 
was adopted with a split ratio of 20:1. Ni-
trogen was used as the carrier gas. The hy-
drogen and compressed air pressures were 
28 psi and 38 psi. The oven was pro-
grammed as follows: initial temperature at 
60 °C for 5 min. First ramping at 10 °C/min 
for 20 min was followed by a second ramp-
ing at 15 °C/min for 4 min. 
 
Determination of phytosterol composition  
Extraction of oil was carried out accord-
ing to AOAC method 999.02 (AOAC Inter-
national, 2002), while the analysis of sterols 
was carried out according to AOAC method 
994.10 (AOAC International, 2000). This 
involved extraction of the lipid fraction 
from homogenized sample material, fol-
lowed by alkaline hydrolysis (saponifica-
tion), extraction of the non-saponifiables, 
clean-up of the extract, derivatisation of the 
sterols, and separation and quantification of 
the sterol derivatives by gas chromato-
graphy (GC) using a capillary column. 
Chromatographic analyses were carried out 
on an HP 6890 (Hewlett Packard, Wilming-
ton, DE, USA), GC apparatus, fitted with a 
flame ionization detector (FID), and pow-
ered with HP Chemstation Rev. A 09.01 
(1206) software, to quantify and identify 
compounds. The column was HP 
INNOWax Column (30 m × 0.25 mm × 
0.25 μm film thickness). The inlet and de-
tection temperatures were 250 and 320 °C. 
Split injection was adopted with a split ratio 
of 20:1. Nitrogen was used as the carrier 
gas. The hydrogen and compressed air pres-
sures were 22 psi and 35 psi. The oven was 
programmed as follows: initial temperature 
at 60 °C, first ramping at 10 °C/min for 
20 min, maintained for 4 min, followed by 
a second ramping at 15 °C/min for 4 min, 
maintained for 10 min.  
 
Determination of tannin composition  
Extraction was carried out according to 
the method of Luthar (1992). The tannin 
fraction of the crude aqueous extract above 
was extracted with methanol and subjected 
to gas chromatographic analysis. Chroma-
tographic analyses were carried out on an 
HP 6890 (Hewlett Packard, Wilmington, 
DE, USA), GC apparatus, fitted with a 
flame ionization detector (FID), and pow-
ered with HP Chemstation Rev. A 09.01 
(1206) software, to quantify and identify 
compounds. The column was HP 5 Column 
(30 m × 0.25 mm × 0.25 μm film thick-
ness). The inlet and detection temperatures 
were 250 and 320 °C. Split injection was 
adopted with a split ratio of 20:1. Nitrogen 
was used as the carrier gas. The hydrogen 
and compressed air pressures were 28 psi 
and 40 psi. The oven was programmed as 
follows: initial temperature at 120 °C, fol-
lowed by ramping at 10 °C/min for 20 min. 
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Experimental design for the anti-diabetic 
study 
Male Wistar albino rats (weighing 180-
200 g at the start of the study) were collect-
ed from the animal house of the Department 
of Physiology, University of Nigeria, Enu-
gu Campus. All the experiments were con-
ducted in accordance with the international-
ly accepted principles for laboratory animal 
use and care as found in the European 
Community Guidelines (EEC Directive of 
1986; 86/609/EEC). The rats were weighed 
and sorted into nine groups (Table 1) of 
five animals each, so that their average 
weights were approximately equal. The an-
imals were housed in plastic cages. After a 
one-week acclimatization period on guinea 
growers mash (Port Harcourt Flour Mills, 
Port Harcourt, Nigeria), the animals were 
fasted overnight, and their baseline fasting 
blood glucose level (FBS) determined using 
multiCareinTM triglyceride strips and glu-
cometer (Biochemical Systems Internation-
al, Arezzo, Italy), by collecting blood via 
tail cut. Diabetes was induced by injection 
of a freshly prepared solution of alloxan 
(80 mg/kg body weight) in normal saline, 
via the tail vein of five groups, while the 
other four groups were injected with normal 
saline alone. The dosage of administration 
of alloxan was adapted from Radwan 
(2001). Three days after administration of 
the alloxan, the animals were again fasted 
and blood collected via tail cutting blood 
(Burcelin et al., 1995), for the determina-
tion of their fasting glucose levels. It was 
found that the rats had moderate diabetes, 
having hyperglycemia (that is, with blood 
glucose of over 150 % of the control). Then 
the rats were kept for 3 days to stabilize the 
diabetic condition (Jyoti et al., 2002) before 
commencing the treatment, which lasted for 
ten days. The DiabetminTM (metformin 
HCl) and extracts were administered daily 
by intra-gastric gavages. The dosages of 
administration of the extracts were adopted 
and modified from Ikewuchi and Ikewuchi 
(2009c) and Ikewuchi et al. (2010). The an-
imals were allowed food and water ad libi-
tum. The fasting glucose levels were taken 
on days 5 and 10. The animals were al-
lowed normal feed and water ad libitum. At 
the end of the treatment period, they were 
weighed, fasted overnight and anaesthetized 
by exposure to chloroform. While under 
anesthesia, they were sacrificed and blood 
was collected from each rat into heparin 
and EDTA sample bottles. Whole blood 
was immediately used to determine the tri-
glyceride levels (using multiCarein strips). 
Then the eyes were removed and stored for 
the determination of the ocular markers of 
oxidative stress. The heparin anti-
coagulated blood samples were centrifuged 
at 1000 g for 10 min, after which their 
plasma was collected and stored for subse-
quent analysis, while the EDTA anti-
coagulated blood samples were used for the 
haematological analysis. 
 
Table 1: Experimental design for the anti-
diabetic screening 
S/N ID Treatment 
1 Normal Normal saline and 
water 
2 Test control Alloxan and water 
3 Reference  
treatment  
(Reference) 
Alloxan and metfor-
min (50 mg/Kg body 
weight) 
4 Treatment  
control I (TPC1) 
Normal saline and 
extract (100 mg/Kg) 
5 Treatment  
control II (TPC2) 
Normal saline and 
extract (200 mg/Kg) 
6 Treatment  
control III (TPC3) 
Normal saline and 
extract (300 mg/Kg) 
7 Treatment I  
(TP1) 
Alloxan and extract 
(100 mg/Kg) 
8 Treatment II 
(TP2) 
Alloxan and extract 
(200 mg/Kg) 
9 Treatment III 
(TP3) 
Alloxan and extract 
(300 mg/Kg) 
 
Determination of the plasma biochemical 
indices 
The plasma glucose concentration was 
determined using the multiCareinTM glu-
cose strips and glucometer (Biochemical 
Systems International, Arezzo, Italy). Plas-
ma triglyceride concentration was deter-
mined using multiCareinTM triglyceride 
strips and glucometer (Biochemical Sys-
tems International, Arezzo, Italy). Plasma 
total and high density lipoprotein cholester-
ol concentrations were assayed enzymati-
cally with Randox commercial test kits 
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(Randox Laboratories, Crumlin, England, 
UK). Plasma VLDL- and LDL-cholesterol 
concentrations were calculated using the 
Friedewald equation (Friedewald, 1972) as 
follows: 
 
ሾܮܦܮ	݄ܿ݋݈݁ݏݐ݁ݎ݋݈ሿ ൬݉݉݋݈ܮ ൰ ൌ 
ሾܶ݋ݐ݈ܽ	݄ܿ݋݈݁ݏݐ݁ݎ݋݈ሿ െ ሾܪܦܮ	݄ܿ݋݈݁ݏݐ݁ݎ݋݈ሿ െ		 ሺTriglycerideሻ2.2  
(Eqn 1) 
 
ሾܸܮܦܮ	݄ܿ݋݈݁ݏݐ݁ݎ݋݈ሿ ൬݉݉݋݈ܮ ൰ ൌ 	
ሺTriglycerideሻ
2.2  
(Eqn 2) 
 
Plasma non-HDL cholesterol concentra-
tion was determined as reported by Brun-
zell et al. (2008): 
 
ሾNon െ HDL	cholesterolሿ
ൌ ሾTotal	cholesterolሿ	– ሾHDL	cholesterolሿ 
(Eqn 3) 
 
The atherogenic indices were calculated 
as earlier reported by Ikewuchi and Ikewu-
chi (2009c, d, 2010) using the following 
formulae: 
 
ܥܽݎ݀݅ܽܿ	ܴ݅ݏ݇	ܴܽݐ݅݋	ሺܥܴܴሻ ൌ 	 ሺܶ݋ݐ݈ܽ	݄ܿ݋݈݁ݏݐ݁ݎ݋݈ሻሺܪܦܮ	݄ܿ݋݈݁ݏݐ݁ݎ݋݈ሻ  
(Eqn 4) 
 
ܣݐ݄݁ݎ݋݃݁݊݅ܿ	ܥ݋݂݂݁݅ܿ݅݁݊ݐ	ሺܣܥሻ
ൌ 	 ሾTotal	cholestrolሿ െ ሺHDL	cholesterolሻሺHDL	cholesterolሻ  
(Eqn 5) 
 
Atherogenic	Index	of	Plasma	ሺAIPሻ ൌ log	ሺTrigylcerideሻ
ሺHDL	cholesterolሻ  
(Eqn 6) 
 
The plasma activities of alanine trans-
aminase, aspartate transaminase, and alka-
line phosphatase, were determined using 
Randox test kits (Randox Laboratories, 
Crumlin, England, UK). The activities of 
alanine and aspartate transaminases were 
respectively measured by monitoring at 
546 nm the concentrations of pyruvate and 
oxaloacetate hydrazones formed with 2,4-
dinitrophenylhydrazine. The activity of al-
kaline phosphatase was determined by 
monitoring the degradation of p-nitro-
phenylphosphate to p-nitrophenol, at 405 
nm. Plasma total and conjugated bilirubin, 
urea and total protein concentrations were 
determined using Randox test kits (Randox 
Laboratories, Crumlin, England, UK). The 
wavelength for the determination of conju-
gated bilirubin and urea was 546 nm and 
that of total bilirubin was 578 nm. Plasma 
total protein was determined by the Biuret 
method using Randox test kits, and the con-
centration of the resultant coloured complex 
was measured at 560 nm. Plasma sodium 
and potassium concentration was deter-
mined by flame photometry, according to 
AOAC Official Method 956.01 (AOAC In-
ternational, 2006). Plasma calcium concen-
tration was determined by the cresol phtha-
lein complexone method (Baginsky et al., 
1973), and the concentration of the resultant 
complex was measured at 575 nm. Plasma 
chloride and bicarbonate concentrations 
were determined by titrimetric methods 
(Cheesbrough, 2006). 
 
Determination of the haematological indi-
ces 
Haematological indices were deter-
mined using Medonic M16 Haematological 
Analyser (Nelson Biomedical Limited., 
UK). 
 
Determination of ocular indices of oxida-
tive stress 
Each eye was homogenized in 4 mL of 
0.001 mol/L phosphate buffer (pH 7.4). The 
resultant homogenate was centrifuged at 
1000 x g for 15 min, and the supernatants 
were collected and stored in the refrigerator 
for the assays. The protein contents of the 
homogenates were determined by the biuret 
method, using Randox test kits (Randox 
Laboratories, Crumlin, England, UK). 
The method adopted for the analysis of 
malondialdehyde was that of Hunter et al. 
(1963) as modified by Gutteridge and Wil-
kins (1982). The concentration of the re-
sultant malondialdehyde - thiobarbituric 
acid complex (or adduct) was measured at 
532 nm. Ascorbic acid content was estimat-
ed by iodine titration as reported by Ikewu-
chi and Ikewuchi (2011). Catalase activity 
was determined according to the method of 
Beers and Sizer (1952). The concentration 
of the residual hydrogen peroxide was 
measured at 420 nm. Superoxide dismutase 
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activity was determined according to the 
method of Misra and Fridovich (1989). The 
degree of inhibition of the auto-oxidation of 
adrenaline (which reflects the activity of 
superoxide dismutase) was determined by 
measuring the concentration of the resultant 
adrenochrome, at 520 nm. The amount of 
enzyme that produced 50 % inhibition was 
defined as one unit of the enzyme activity. 
 
Statistical analysis of data 
All values are reported as the mean ± 
standard error in the mean (s.e.m.). The 
values of the variables were analyzed for 
statistically significant differences using the 
Student’s t-test, with the help of SPSS Sta-
tistics 17.0 package (SPSS Inc., Chicago 
Ill). P<0.05 was assumed to be significant. 
Graphs were drawn using Microsoft Office 
Excel, 2010 software. 
 
RESULTS 
Table 2 shows the alkaloid composition 
of an aqueous extract of the leaves of T. 
procumbens. Thirty nine known alkaloids 
were detected, consisting mainly of 
73.91 % akuamidine, 22.33 % voacangine, 
1.27 % echitamine, 0.55 % echitamidine, 
0.36 % lupanine, 0.27 % crinamidine, 
0.23 % augustamine and 0.10 % 6-
hydroxypowelline.  
 
Table 2: The composition of the alkaloid frac-
tion of an aqueous extract of the leaves of 
Tridax procumbens 
Compounds Retention 
time (min) 
Composi-
tion 
(mg/kg) 
Choline  7.096 0.007442 
Trigonelline 7.641 Not detected 
Angustifoline 8.109 Not detected 
Sparteine 8.952 0.002921 
Ellipcine 9.680 0.006273 
Lupanine 11.041 0.105692 
13-α-
Hydrorhombifoline 
11.286 0.006579 
9-Octadecenamide 12.936 0.006590 
Dihydro-oxo-
demethoxyhae-
manthamine 
14.150 0.011062 
Augustamine 14.918 0.068184 
Oxoassoanine 15.395 0.009922 
 
Compounds Retention 
time 
(min) 
Composition 
(mg/kg) 
Cinchonidine 16.246 0.018697 
Cinchonine 16.369 0.011521 
Crinane-3α-ol 16.491 0.025934 
Buphanidrine 16.669 0.011993 
Indicine-N-oxide 17.547 0.010321 
Powelline 18.590 0.013073 
Undulatine 18.840 0.009488 
Ambelline 19.678 0.005772 
6-Hydroxy- 
buphanidrine 
20.473 0.021053 
Acronycine 21.130 0.019698 
Monocrotaline 21.328 0.021175 
6-Hydroxypowel-
line 
21.821 0.029815 
Nitidine 22.366 0.013351 
Crinamidine 23.968 0.079650 
1β,2β-Epoxy- 
ambelline 
24.616 0.021799 
6-Hydroxy- 
undulatine 
24.791 0.016275 
Epoxy-3,7-dimeth-
oxycrinane-11-one 
25.482 0.002423 
Akuamidine 26.837 21.568600 
Echitamidine 26.952 0.161556 
Voacangine 27.062 6.516560 
Mitraphylin 27.649 0.000004 
Camptothecin 28.096 0.004965 
Echitamine 28.644 0.370808 
Colchicine 28.862 0.002308 
Emetine 29.578 0.000822 
Tetrandrine 29.743 0.000327 
Thalicarpin 30.164 0.000024 
Paclitaxel 32.338 0.000195 
Total   29.182800 
 
Table 3 shows the phytosterol and tan-
nin composition of an aqueous extract of 
the leaves of T. procumbens. The sterol 
fraction consisted 100 % of sitosterol, with 
cholesterol, cholestanol, ergosterol, cam-
pesterol, stigmasterol and 5-avenasterol not 
detected. The tannin fraction consisted 
100 % of tannic acid. 
 
Table 3: Composition of the phytosterol and 
tannin fractions of an aqueous extract of the 
leaves of Tridax procumbens 
Compounds Retention 
time 
(min) 
Composition 
(mg/kg) 
Phytosterols   
Sitosterol 24.790 115.79 
Tannins   
Tannic acid 19.201 5294.78 
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Table 4 shows the time course of the ef-
fect of an aqueous extract of the leaves of T. 
procumbens of the plasma glucose levels of 
normal and alloxan treated rats. On day 0, 
the plasma fasting glucose concentration of 
the alloxan treated animals were signifi-
cantly higher (P<0.05) than the untreated 
animals (Normal, Treatment control 1, 
Treatment control 2 and Treatment control 
3). On days 5 and 10, the plasma fasting 
glucose levels of the animals administered 
the extracts were significantly lower 
(P<0.05) than corresponding Test controls 
and values on day 0. The percentage reduc-
tions in plasma fasting glucose levels of the 
treated rats on days 5 and 10, were signifi-
cantly higher (P<0.05) than the correspond-
ing values of the Test control group. 
Tables 5 and 6 show the effect of an 
aqueous extract of the leaves of T. procum-
bens on the plasma lipid profiles and ather-
ogenic indices of normal and alloxan treat-
ed rats. The 300 mg/kg treatment produced 
a significantly lower (P<0.05) plasma tri-
glyceride and VLDL cholesterol levels, 
compared to Test control. There were no 
significant differences in the total-, HDL-, 
LDL- and non-HDL cholesterol levels, as 
well as the atherogenic indices of the test 
groups and Test control. The cardiac risk 
ratio and atherogenic coefficient of Treat-
ment 1 and the atherogenic index of plasma 
of Treatment 3 were lower though not sig-
nificantly than the Test control. 
 
Table 4: Effect of an aqueous extract of the leaves of Tridax procumbens on the plasma glucose pro-
files of normal and alloxan-induced diabetic rats 
Treatment group Magnitude 
Day 0 (mg/dL) Day 5 Day 10 
Value (mg/dL) % Reduction Value (mg/dL) % Reduction
Normal 96.00±3.11a 98.35±4.63a -3.55±8.68a,d 104.20±2.27a,b,d -9.11±4.95a 
Test control 155.40±48.67c 208.00±16.07c,* -65.45±29.31c 179.50±29.11c,* -50.27±33.96c
Reference  
treatment 
105.90±0.87d 89.33±0.94a,d,* 15.65±0.25d,e 110.00±9.61d,* -3.95±9.52a 
Treatment control 1 91.75±2.97a 83.00±3.92d,* 9.69±1.58a,f 106.00±1.76d,e,* -13.13±5.32a,c
Treatment control 2 85.75±2.29a 51.25±4.04e,* 39.71±6.12b,g 108.00±3.56a,d,* -26.66±7.34a,c
Treatment control 3 82.50±1.72e 66.67±2.11f,* 18.91±3.98b,e,f 100.00±3.13b,e,* -21.66±6.03c 
Treatment 1 146.33±4.13c 111.00±2.53g,* 24.06±1.33b 128.33±2.54f,* 12.12±2.29b 
Treatment 2 138.67±1.97f 91.00±2.24a,d,* 34.31±2.01g 122.00±3.85a,g,* 12.05±2.19b 
Treatment 3 233.33±4.32b 151.00±3.03b,* 35.19±1.76g 134.00±5.79f,g,* 42.31±3.57d 
Values are mean ± s.e.m., n=5, per group. 
a,b,cValues in the same column with different superscripts are significantly different at P<0.05. 
*P<0.05 compared to corresponding values on day 0. 
 % reduction = percentage reduction from the corresponding values on day 0. 
 
Table 5: Effect of an aqueous extract of the leaves of Tridax procumbens on the plasma lipid profile of 
normal and alloxan-induced diabetic rats 
Treatment group Concentration (mmol/L)
Triglyceride Total 
cholesterol 
HDL 
cholesterol 
VLDL 
cholesterol
LDL 
cholesterol 
Non-HDL 
cholesterol 
Normal 0.80±0.04a 1.89±0.05a,b,d 1.11±0.02c,d 0.37±0.02c 0.41±0.07c,k 0.78±0.06a,c 
Test control 0.84±0.04a,b 1.74±0.04a 0.73±0.15a,c,k 0.38±0.02a,c 0.63±0.15a,c,d,f 1.01±0.14a,c 
Reference treatment 0.88±0.05b 2.24±0.18a,b,d 1.26±0.14a,b,c,d 0.40±0.02a 0.58±0.28a,c,d,f 0.98±0.26a,c 
Treatment control 1 0.96±0.05a,b 1.81±0.11a,b,d 1.16±0.07d 0.43±0.02a,c 0.23±0.05b,d 0.67±0.04a 
Treatment control 2 0.83±0.04a 1.86±0.27a,b,d 0.91±0.05b,k,l 0.38±0.02c,f 0.57±0.33a,b,c,f 0.95±0.32a,b,c 
Treatment control 3 0.97±0.07b 1.78±0.03a,b 1.39±0.10d 0.44±0.03a,f -0.04±0.11b 0.40±0.09b 
Treatment 1 0.82±0.14a,b,d 2.01±0.12a,c 0.83±0.05a 0.37±0.06a,b,c 0.80±0.10a,c 1.18±0.14c 
Treatment 2 1.02±0.09a,b 2.03±0.05c,d 1.04±0.12a,b,c,d 0.46±0.04a,c 0.53±0.19a,c,d,f 0.99±0.16a,c 
Treatment 3 0.58±0.01d 1.63±0.06b 0.91±0.04a,l 0.27±0.00b 0.45±0.02f,k 0.72±0.02a 
Values are mean ± s.e.m., n=5, per group. 
a,b,cValues in the same column with different superscripts are significantly different at P<0.05. 
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Table 6: Effect of an aqueous extract of the leaves of Tridax procumbens leaves on the atherogenic 
indices of normal and alloxan-induced diabetic rats 
Treatment group Magnitude 
Cardiac risk ratio Atherogenic coefficient Atherogenic index of  
plasma 
Normal 1.70±0.07a,c 0.70±0.07a,c -0.14±0.02c,f 
Test control 2.74±0.44a,c 1.74±0.44a,c  0.09±0.06a 
Reference treatment 1.89±0.32a,b,c 0.89±0.32a,b,c -0.15±0.05d,f,h 
Treatment control 1 1.59±0.03a 0.59±0.03a -0.08±0.04b,c,d 
Treatment control 2 2.15±0.49a,b,c 1.15±0.49a,b,c -0.04±0.03a,b,h 
Treatment control 3 1.31±0.09b 0.31±0.09b -0.16±0.02d,f 
Treatment 1 1.65±0.54a,b,c 0.65±0.54a,b,c -0.03±0.07a,b,c,d,f 
Treatment 2 2.06±0.26a,c 1.06±0.26a,c -0.01±0.04a,b,c 
Treatment 3 1.79±0.01c 0.79±0.01c -0.19±0.01f 
Values are mean ± s.e.m., n=5, per group. 
a,b,cValues in the same column with different superscripts are significantly different at P<0.05. 
 
 
Tables 7 and 8 show the effect of an 
aqueous extract of the leaves of T. procum-
bens on the plasma biochemistry of normal 
and alloxan treated rats. The alkaline phos-
phatase activity of the animals on Treat-
ment 2 was significantly lower (P<0.05) 
than Test control, while that of Treatment 3 
was significantly higher (P<0.05). The 
plasma alanine transaminase activity, urea, 
blood urea nitrogen and total bilirubin lev-
els of Treatment 1 and Treatment 2 were 
significantly lower (P<0.05) than Test con-
trol, while that of Treatment 3 was higher, 
though not significantly. The aspartate 
transaminase activity of Treatment 2 and 
Treatment 3 were significantly lower 
(P<0.05) than Test control, while that of 
Treatment 1 was not. The plasma calcium 
level of the animals on Treatment 1 was 
significantly higher (P<0.05) than Test con-
trol; those of Treatment 2 and Treatment 3 
were not significantly different. There were 
no significant differences between the 
plasma conjugated and unconjugated bili-
rubin, unconjugated/conjugated bilirubin 
ratio, total protein, sodium, potassium and 
chloride levels of the tests and Test control. 
The plasma bicarbonate level of the animals 
on Treatment 3 was significantly lower 
(P<0.05) than Test control, while those of 
Treatment 1 and Treatment 2 were not. 
 
 
 
Table 7: Effect of an aqueous extract of the leaves of Tridax procumbens on the plasma hepatospecif-
ic markers of normal and alloxan-induced diabetic rats 
Treatment 
group 
Magnitude 
Alkaline  
phosphatase 
activity (U/L) 
Alanine trans-
aminase 
activity (U/L) 
Aspartate 
transaminase 
activity (U/L) 
Total 
bilirubin 
level 
(µmol/L) 
Direct 
bilirubin 
level 
(µmol/L) 
Unconjugated 
bilirubin level 
(µmol/L) 
Free/direct 
bilirubin 
ratio 
Total  
protein 
level 
(mg/dL) 
Normal 316.2±15.5d 23.5±2.8a,c 25.9±0.9a,f 2.9±0.1a,d 2.3±0.1a,c 0.7±0.1a 0.3±0.0a,c 51±0.8a 
Test control 567.9±121.6d 25.6±0.3a 27.4±0.7a,d,f 3.5±0.2c,f 2.7±0.2c 0.8±0.0a,b,d 0.3±0.0a,c 60±2.2b,c 
Reference 
treatment  
176.6±1.2d 21±0.3c 27.1±3.1a,d,f 3.6±0.1c,f 2.2±0.1a,c 1.4±0.2d 0.7±0.1b 57.6±2.8a,b
Treatment 
control 1 
334.0±85.2a,d 30.5±1.8a,d 23.2±1.3a,b,f 2.5±0.1b 1.6±0.2f 0.8±0.2a,c 0.6±0.2a,b,c 54.7±1.6a,b
Treatment 
control 2 
411.9±73.9a,d 34.9±2.1a 24.9±2.3a,b,f 2.0±0.2h 1.3±0.1b 0.7±0.2a,b 0.6±0.2a,b,c 57.8±3.2a,b
Treatment 
control 3 
413.1±109.6a,b,d 28.5±3.3a,c 22.2±1.2a,b,c,l 2.5±0.2a,b 2.0±0.2a,f 0.6±0.2a,b 0.3±0.2a,b,c 57.0±0.8b 
Treatment 1 575.5±134.9a,b,d 23.36±2.2c,d 23.8±1.6f,h 3.0±0.1a,d 2.1±0.3a,b,c,f 1.0±0.2a,b,d 0.6±0.2a,b,c 64.9±1.1c 
Treatment 2 391.9±93.4a 22.2±1.1c 17.0±2.3h,l 3.1±0.2d,f 2.4±0.1a,c 0.7±0.1a,b 0.3±0.1c 52.2±2.5a,b
Treatment 3 941.2±107.4b 31.7±1.3a,d 17.7±1.1c,l 3.6±0.0c 2.5±0.2a,c 1.2±0.1b,c,d 0.5±0.1a,b 56.2±1.2b 
Values are mean ± s.e.m., n=5, per group. 
a,b,cValues in the same column with different superscripts are significantly different at P<0.05.
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Table 8: Effect of an aqueous extract of the leaves of Tridax procumbens on the plasma electrolyte 
profiles of normal and alloxan-induced diabetic rats 
Treatment 
group 
Concentration
Urea 
(mmol/L) 
Blood Urea 
Nitrogen (BUN, 
mg/dL) 
Calcium 
(mmol/L) 
Sodium 
(mg/dL) 
Potassium 
(mg/dL) 
Chloride 
(meq/L) 
Bicarbonate 
(meq/L) 
Normal 20.9±2.2a,c   58.7±6.1a 2.1±0.1a,d 129.2±0.8a,b 5.2±0.2a   98.8±1.5a,b 18.2±0.6a,b,c 
Test control 43.7±1.3f 122.8±3.8d 1.9±0.1b,k 130.0±0.7a,b 5.1±0.1a,b   98.5±0.7a 19.5±0.5a 
Reference 
treatment 
12.7±2.3d   35.6±6.4c 2.0±0.1b,d,f 148.7±12.4a,b 9.2±1.9a,b 114.7±10.1a,b 18.0±0.5c 
Treatment  
control 1 
14.7±0.7d   41.4±2.0c 2.1±0.1a,d 142.0±8.5a,b 5.2±0.4a,b 146.5±37.3a,b 18.0±2.2a,b,c 
Treatment  
control 2 
15.7±0.9a,b,d   44.0±2.6a,c 2.1±0.0a,d 130.8±1.2a,b 5.0±0.2a,b 102.8±1.4a,b 15.3±1.6b,c 
Treatment  
control 3 
17.1±1.0b,h   48.0±2.9d,f 1.9±0.1b,f 128.0±1.8a,b 5.7±0.5a,b   97.3±1.6a,b 14.3±1.0b 
Treatment 1 26.6±3.9a,c,h   74.7±11.1a,f 2.2±0.0a 133.5±1.1a 5.3±0.2a,b   97.7±1.3a,b 17.3±0.7a,c,d 
Treatment 2 23.8±1.8c,h   66.7±4.9a 2.1±0.1a,b,d,f 131.3±1.0a,b 4.8±0.1b 102.8±1.7b 17.3±0.9a,c,f 
Treatment 3 54.2±0.5k 152.1±1.4b 1.9±0.0f,k 128.0±0.7b 5.4±0.1a   97.0±2.8a,b 16.0±0.5b,d,f 
Values are mean ± s.e.m., n=5, per group. 
a,b,cValues in the same column with different superscripts are significantly different at P<0.05. 
 
 
 
Table 9 shows the effect of an aqueous 
extract of the leaves of T. procumbens on 
ocular markers of oxidative stress of normal 
and alloxan treated rats. The ocular ascorbic 
acid contents of the test animals were high-
er than the Test control; with Treatment 2 
being significantly so (P<0.05). There were 
no significant differences in the ocular 
malondialdehyde levels of all the groups. 
The ocular catalase activities of the test an-
imals were lower though not significantly 
than the Test control. The ocular superoxide 
dismutase activities of the test animals were 
lower than the Test control; with Treatment 
3 being significantly so (P<0.05). 
Table 10 shows the effect of an aqueous 
extract of the leaves of T. procumbens on 
the haematological indices of normal and 
alloxan treated rats. The haematocrit, red 
cell and monocyte counts of Treatment 2 
and Treatment 3 were higher though not 
significantly, than Test control, while that 
of Treatment 1 was lower. The haemoglo-
bin concentrations of Treatment 2 and 
Treatment 3 were significantly higher 
(P<0.05) than Test control, while that of 
Treatment 1 was lower. There were no sig-
nificant differences in the total white cell 
counts, mean cell volume, mean cell hae-
moglobin and mean cell haemoglobin con-
centrations of the test groups and Test con-
trol. The neutrophil count of Treatment 2 
was significantly higher (P<0.05) than Test 
control, while those of Treatment 1 and 
Treatment 3 were not. The lymphocyte 
count of Treatment 2 was significantly low-
er (P<0.05) than Test control, while those 
of Treatment 1 and Treatment 3 were not. 
The platelet counts of the test groups were 
higher (though not significantly) than the 
Test control. Figure 1 shows the frequency 
distribution of the effect of an aqueous ex-
tract of the leaves of T. procumbens on the 
cell morphology of normal and alloxan 
treated rats. All the cells from the animals 
on Treatment 2 and Treatment 3 were 
normochromic and normocytic, while those 
from Treatment 1 were 66 % hypochromic 
and 33 % normochromic; and 25 % poikil-
ocytic, 50 % normocytic and 25 % aniso-
cytic. This result shows that the extract had 
no deleterious effect on red cell morpholo-
gy. 
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Figure 1: Frequency distribution of the effect of an aqueous extract of the leaves of Tridax procum-
bens on red cell morphology of normal and alloxan-induced diabetic rats. TPC1 = Treatment control 1, 
TPC2 = Treatment control 2, TPC3 = Treatment control 3, TP1 = Treatment 1, TP2 = Treatment 2, 
TP3 = Treatment 3. 
 
Table 9: Effect of an aqueous extract of the leaves of Tridax procumbens on ocular markers of oxida-
tive stress in normal and alloxan-induced diabetic rats 
Treatment group Magnitude 
Ascorbic acid  
content  
(µmole/g protein)
Malondialdehyde  
content  
(µmol/g protein) 
Catalase activity 
(Units/mg  
protein) 
SOD activity 
(Units/mg  
protein) 
Normal  11.23±1.71a,b,c,h 0.09±0.01a,c,d 20.60±3.61a,c 0.20±0.02a,c 
Test control   8.72±0.34a,f 0.09±0.01c,d 25.84±3.68a,b,c,d 0.16±0.02c,d,f,k 
Reference treat-
ment 
  8.30±0.42c,f,k 0.07±0.01d 23.43±0.49c,d 0.18±0.00f 
Treatment control 1 11.39±3.00a,b,c,h 0.12±0.01a,b,c 30.00±1.57b 0.23±0.014b,c 
Treatment control 2 12.31±1.43a,b 0.08±0.02c,d 22.62±2.70a,b,c,d 0.15±0.03b,d,f,h,k 
Treatment control 3   7.50±0.05h,k 0.15±0.02b 19.39±0.17a 0.07±0.00a,l 
Treatment 1 10.32±0.92a,b,c 0.11±0.01a,c 23.75±1.53c,d 0.14±0.01h,k 
Treatment 2 19.43±3.33b 0.09±0.01a,b,c,d   18.5±1.29a 0.12±0.01d 
Treatment 3 12.90±2.48a,b,c,h 0.12±0.01a 19.48±0.12a 0.05±0.01l 
Values are mean ± s.e.m., n=5, per group. 
a,b,cValues in the same column with different superscripts are significantly different at P<0.05. 
 
 
DISCUSSION 
Alloxan induced diabetes mellitus is of-
ten characterized by decreased levels of in-
sulin and high density lipoprotein, hyper-
glycemia, elevated triglycerides and total 
cholesterol (Hemalatha, 2008). The high 
percentage reduction in plasma glucose lev-
els, produced by the extract in this study, 
supports the use of the leaves in the man-
agement of diabetes mellitus. The extract 
may exert its antihyperglycemic activity by 
stimulating insulin secretion from pancreat-
ic β cells exerting insulin like activity, or by 
converting pro-insulin to insulin, or alterna-
tively, by inhibiting hepatic gluconeogene-
sis. The hypoglycemic effect of the extract 
may have been produced by the saponins 
(Ikewuchi et al., 2009), tannic acid and β-
sitosterol (Table 3) present in the leaves. 
Saponins (Soetan, 2008), tannic acid (Liu et 
al., 2001, 2005; Muthusamy et al., 2008; 
Pereira et al., 2009) and β-sitosterol (Ivorra 
et al., 1988; Beta-sitosterol Monograph, 
2001) are compounds with established hy-
poglycemic activity. The extract may exert 
its antihyperglycemic activity by enhancing 
glucose uptake (by tannic acid), stimulation 
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of insulin secretion from pancreatic β cells 
(by β-sitosterol) and insulin like activity, or 
by conversion of pro-insulin to insulin, or 
alternatively, by inhibition of hepatic glu-
coneogenesis. 
A high plasma triglyceride level is both 
an independent and synergistic risk factor 
for cardiovascular diseases (Dobiásová, 
2004; McBride, 2007; Martirosyan et al., 
2007); and is often associated with hyper-
tension (Lopes et al., 1997; Zicha et al., 
1999), abnormal lipoprotein metabolism, 
obesity, insulin resistance and diabetes 
mellitus (McBride, 2007; Franz et al., 2002; 
Shen, 2007). The 300 mg/kg treatment sig-
nificantly reduced plasma levels of triglyc-
erides (Table 4). This effect may have been 
mediated by the flavonoid (Ikewuchi et al., 
2009) and tannic acid (Table 3) contents of 
the leaves. Flavonoids (Middleton et al., 
2000) and tannic acid (Park et al., 2002) are 
reported to decrease plasma levels of tri-
glycerides. 
High plasma levels of VLDL cholester-
ol is a risk factor for cardiovascular disease 
(Ademuyiwa et al., 2005; Lichtenstein et 
al., 2006) and often accompanies diabetes 
mellitus (Brunzell et al., 2008; Shen, 2007; 
Rang et al., 2005) and obesity (Krauss et 
al., 2006). In this study, we observed a sig-
nificantly lower plasma VLDL cholesterol 
level in the treated animals. This cholesterol 
lowering effect of the extract may be due to 
its content of β-sitosterol and tannic acid 
(see Table 3) which are known to have cho-
lesterol lowering and atheroprotective activ-
ity (Dillard and German, 2000; Yugarani et 
al., 1993; Piironen et al., 2000; Park et al., 
2002; Bouic, 2003; Berger et al., 2004; 
Basu et al., 2007). Thus, anyone or a com-
bination of some or all of the above men-
tioned components could have been respon-
sible for the hypocholesterolemic effect of 
the extract, observed in this study.  
The treatment dose dependently lowered 
(though not significantly) the atherogenic 
indices of the animals. Atherogenic indices 
are powerful indicators of the risk of heart 
disease: the higher the value, the higher the 
risk of developing cardiovascular disease 
and vice versa (Dobiásová, 2004; Mar-
tirosyan et al., 2007; Brehm et al., 2004; 
Usoro et al., 2006). Low atherogenic indi-
ces are protective against coronary heart 
disease (Usoro et al., 2006). 
These results indicate that the extract 
has a dose dependent positive effect on the 
integrity and function of the liver and kid-
ney of the diabetic rats. The extract im-
proved the lowered plasma calcium level 
produced by the diabetic condition. The 
significance of this cannot be overempha-
sized. Many neuromuscular and other cellu-
lar functions depend on the maintenance of 
the ionized calcium concentration in the 
extracellular fluid (Crook, 2006). Calcium 
fluxes are also important mediators of hor-
monal effects on target organs through sev-
eral intracellular signaling pathways, such 
as the phosphoinositide and cyclic adeno-
sine monophosphate systems (Crook, 2006; 
FAO, 2004). The extract may have 
achieved this by affecting parathyroid hor-
mone secretion. This hormone increases the 
renal tubular reabsorption of calcium, pro-
motes intestinal calcium absorption by 
stimulating the renal production of 1,25-
dihydroxyvitamin D or calcitriol (1,25-
(OH)2D), and, if necessary, resorbs bone 
(Crook, 2006; Brown and Hebert, 1997). 
Collectively, these results indicate that the 
extract dose dependently improved the liver 
and kidney functions. 
Ascorbic acid functions as an important 
component of the cellular defense against 
oxygen toxicity and lipid peroxidation 
which is caused by the free radical mecha-
nism. Reduced levels and the altered meta-
bolic turnover of ascorbic acid have been 
reported in diabetic patients. A decrease in 
the plasma concentration of ascorbic acid 
has been observed in diabetic patients (Ata-
lay and Laaksonen, 2002; Samuel et al., 
2010). The uptake of ascorbic acid into the 
cell is mediated by processes which  are  re- 
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Table 10: Effect of an aqueous extract of the leaves of Tridax procumbens leaves on the haematological indices of normal and alloxan-induced diabetic rats 
Parameter Magnitude 
 Normal Test control Reference Treatment 
control 1 
Treatment 
control 2 
Treatment 
control 3 
Treatment 1 Treatment 2 Treatment 3 
Haematocrit (%) 34.4±2.6a,b,c 38.8±2.2a,c 31.0±0.5b 39.5±2.4a,c 36.5±2.6a,b,c 39.0±1.6a,c 35.0±2.5b,c 42.3±1.3a 42.0±1.0a 
Haemoglobin concentra-
tion (g/dL) 
12.0±0.5a,b,c 12.3±0.5a,c 11.4±0.1c 13.0±0.5a,b,f 12.2±0.6a,b,c 12.3±0.4a,c 11.6±0.7c,f 13.9±0.3b 13.4±0.3a,b 
Red cell count (x 109 
cells/L) 
  5.7±0.2a,c   6.7±0.4a,b,f   5.5±0.0c,d   7.0±0.5b,f   6.4±0.4a,b,c,d,f   6.9±0.2b,f   6.3±0.4c,d,f   7.4±0.2b   7.2±0.4a,b 
Total white cell count 
(x109 cells/L) 
  9.7±1.1a 11.9±1.3b 10.2±1.0a,b 18.7±3.1b 17.3±3.6a,b 13.7±1.3a,b 12.0±1.4a,b 11.6±3.9a,b 10.6±0.3a,b 
Neutrophils (%)   5.3±1.0a,c   3.7±0.4c   5.5±1.4c   5.0±1.9b,c,   6.4±1.5a,b,c 11.3±1.3a   5.3±1.0a,c 10.3±0.2b   4.5±0.2c 
Lymphocytes (%) 81.7±3.7a,b,c 83.3±2.3a 77.5±1.4a,c 84.0±4.1a,c 79.4±2.5b,c 72.7±0.8b 85.3±2.9a,c 75.3±3.3b,c 81.0±1.6a,c 
Monocytes (%) 12.8±2.7a,b,c 12.8±2.0a,b,c 15.6±1.4a 11.0±2.5a,b,c 14.9±1.5a,c 16.6±0.7a,c   9.5±1.8b 14.5±3.3a,b,c 14.5±1.5a,b,c 
Eosinophils (%)   0.0±0.0a   0.0±0.0a   0.0±0.0a   0.0±0.0a   0.0±0.0a   0.0±0.0a   0.0±0.0a   0.0±0.0a   0.0±0.0a 
Basophils (%)   0.0±0.0a   0.0±0.0a   0.0±0.0a   0.0±0.0a   0.0±0.0a   0.0±0.0a   0.0±0.0a   0.0±0.0a   0.0±0.0a 
Mean cell volume (fL) 58.7±3.2a,b 57.5±1.5a,b 56.5±0.5a 57.5±1.9a,b 57.0±1.0a,b 59.9±1.6b 55.5±1.1a,b 57.5±1.3a,b 57.8±1.2a,b 
Mean cell haemoglobin 
concentration (g/dL) 
35.5±1.2a,b,d 34.1±0.5a,b,d 36.3±0.6a 33.4±0.4b 32.2±1.7b,f 34.5±1.0a,b,d 36.5±0.7a,d 34.6±0.3d,f 33.9±0.3b,f 
Mean cell haemoglobin 
(pg/cell) 
20.8±0.7a,b 19.8±0.3a,b 20.5±0.2a 19.1±0.5a,b 19.7±0.1b 19.4±0.1b 20.1±0.6a,b 19.9±0.4a,b 19.5±0.4b 
Platelet count 
(x103cells/mm3) 
447.8±33.3a,c 340.8±54.1c,d 343.0±8.9d 494.0±29.5b,c 425.5±54.8a,c,d 581.9±24.4b 396.0±26.5a,d 503.7±66.3a,b,c,d 431.5±4.9a,c 
Values are mean ± s.e.m., n=5, per group. 
a,b,cValues in the same row with different superscripts are significantly different at P<0.05. 
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lated to glucose transport and it has been 
shown that the high extracellular glucose 
concentration in diabetes may further im-
pair the cellular uptake of ascorbic acid and 
accentuate the problems which are associat-
ed with its deficiency (Samuel et al., 2010). 
Studies show that ascorbic acid protects the 
lens and other tissues of the eye from light 
damage (Varma, 1991; Taylor, 1993). So, 
these increases caused by the extract, por-
tends a consolidation of antioxidant status 
of the tissues, hence protection of these tis-
sues from free radical damage. This high 
ocular content of ascorbic acid may have 
been produced by the high content of 
ascorbic acid in the leaves (Ikewuchi and 
Ikewuchi, 2009a). 
Numerous reports indicate variations in 
the levels of antioxidants in the diabetic pa-
tients (Samuel et al., 2010; Hartnett et al., 
2000). Therefore, though the lowered en-
zyme activities produced by the extract may 
portend compromised antioxidant protec-
tion; the antioxidant vitamins in the test rats 
clearly indicate that the extract protects 
against oxidative stress in ocular tissues and 
probably may have cushioned against the 
compromised antioxidant enzymes.  
The extract had a dose dependent posi-
tive effect on the haemopoietic system of 
the test rats. It increased (though not signif-
icantly) the red cell mass, haematocrit and 
monocyte counts, and platelet number; sig-
nificantly increased haemoglobin concen-
tration and neutrophil count, while decreas-
ing lymphocyte count. That the extract im-
proved the haemoglobin concentration and 
heamatocrit highlights the potential of the 
plant in the management of anaemia. This 
property may be attributable to the iron 
contained by the leaves (Ikewuchi and 
Ikewuchi, 2009b). 
 
CONCLUSIONS 
This study showed that the extract was 
hypoglycemic, positively affected the hae-
mopoietic system and integrity and function 
(dose dependently) of the liver and kidney 
of the diabetic rats; improved the lipid pro-
file and had no deleterious effect on red cell 
morphology. The profiles of malondialde-
hyde and antioxidant vitamins in the test 
rats clearly indicate that the extract protects 
against oxidative stress in ocular tissues. 
This study also revealed the presence of 
pharmacologically active compounds in the 
leaf extract. All of these, highlight the car-
dioprotective potential of the leaves of 
Tridax procumbens, and support its use in 
traditional health care practices for the 
management of diabetes mellitus. 
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